ArticleInternational journal of women's health2026
Disease Burden Attributable to Hip Fractures in Asian Women.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study is the first to comprehensively evaluate the disease burden of hip fractures in Asian women, presenting epidemiological trends from 1990 to 2023. Methods: Data on hip fractures among women in Asian countries and regions were sourced from the 2023 Global Burden of Disease(GBD) Study, covering incidence, prevalence, and years lived with disability (YLDs) from 1990 to 2023. Secondary analysis of these data yielded the overall disease burden of hip fractures and attributable risk factors among Asian women. Building on this information, we further reported the epidemiological trends of hip fractures among women across Asian countries and regions. We used an autoregressive integrated moving average (ARIMA) model to project the disease burden of hip fractures among Asian women over the next 15 years. Results: In 2023, the total incidence of hip fracture among Asian women was 6,307,956 (4,029,635-9,519,173), with an ASIR of 278.43 (178-419.48). Based on Joinpoint regression, the AAPC of the age-standardized incidence rate (ASIR) of hip fractures in Asian women from 1990 to 2023 was 1.79 (95% CI: 1.74-1.84), P < 0.05. Falls are the leading cause of hip fractures among Asian women. Based on the ARIMA model, by 2040 the age-standardized incidence rate (ASIR) of hip fracture in Asian women is projected to be 346.62 (95% CI: 299.40-393.84) per 100,000, with 10,699,484 (6,416,769-14,982,198) new cases. Conclusion: In Asia, hip fracture in women constitutes a substantial and growing disease burden; promoting fall-prevention initiatives across the continent is essential to curb further increases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.